These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 2084067)

  • 1. Evaluation of a platinum-doxorubicin complex in experimental tumor systems.
    Zunino F; Pratesi G; Formelli F; Pasini A
    Invest New Drugs; 1990 Nov; 8(4):341-5. PubMed ID: 2084067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
    Goldin A; Venditti JM; Geran R
    Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
    Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
    Tashiro T; Kawada Y; Sakurai Y; Kidani Y
    Biomed Pharmacother; 1989; 43(4):251-60. PubMed ID: 2790145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
    Kobayashi H; Takemura Y; Miyachi H; Ogawa T
    Invest New Drugs; 1991 Nov; 9(4):313-9. PubMed ID: 1804804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
    Bissery MC; Nguyen CH; Bisagni E; Vrignaud P; Lavelle F
    Invest New Drugs; 1993 Nov; 11(4):263-77. PubMed ID: 8157469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts.
    Taetle R; Howell SB; Giuliani FC; Koziol J; Koessler A
    Cancer; 1982 Oct; 50(8):1455-61. PubMed ID: 6956427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G; Lattuada D; Morelli S; Nicolin A; Cubeddu R; Taroni P; Valentini G
    Cancer Lett; 1995 Jul; 93(2):255-9. PubMed ID: 7621437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.
    Manzotti C; Pratesi G; Menta E; Di Domenico R; Cavalletti E; Fiebig HH; Kelland LR; Farrell N; Polizzi D; Supino R; Pezzoni G; Zunino F
    Clin Cancer Res; 2000 Jul; 6(7):2626-34. PubMed ID: 10914703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
    Ganzina F
    Cancer Treat Rev; 1983 Mar; 10(1):1-22. PubMed ID: 6342772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
    Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
    Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors.
    Formelli F; Cleris L; Carsana R
    Cancer Chemother Pharmacol; 1988; 21(4):329-36. PubMed ID: 3370742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.
    Pratesi G; De Cesare M; Caserini C; Perego P; Dal Bo L; Polizzi D; Supino R; Bigioni M; Manzini S; Iafrate E; Salvatore C; Casazza A; Arcamone F; Zunino F
    Clin Cancer Res; 1998 Nov; 4(11):2833-9. PubMed ID: 9829750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.